2017 年制药行业。从分子角度对 FDA 药物批准的分析。

KRISP, College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South Africa.

School of Chemistry and Physics, University of KwaZulu-Natal, Durban 4001, South Africa.

Molecules. 2018 Feb 27;23(3):533. doi: 10.3390/molecules23030533.

This is an analysis from a chemical point of view of the 46 drugs (34 New Chemical Entities and 12 Biologics) approved by the FDA during 2017. The drugs included in the 2017 "harvest" have been classified on the basis of their chemical structure: biologics (antibodies and proteins); peptides; amino acids and natural products; drug combinations; and small molecules.

这是对 2017 年美国食品和药物管理局批准的 46 种药物（34 种新化学实体和 12 种生物制剂）从化学角度进行的分析。2017 年“收获”中包含的药物根据其化学结构进行了分类：生物制剂（抗体和蛋白质）；肽；氨基酸和天然产物；药物组合；小分子。